We have only begun to tap Femtech’s potential to radically improve health outcomes globally.
Collaborate on globally scalable products that can deliver superior healthcare outcomes.
Clinics are paid royalties for their contribution and will be first to market using world leading AI technology for their patients.
Collaboration is easy, regardless of clinic size or location. Clinics only need to provide data access, expertise and clinical support. Presagen does the rest, including AI build, regulatory approvals and commercialization.
All data is private, secure and locally hosted; it is not shared to a central location or outside of your local jurisdiction.
Learn more about our AI Open Projects technology.
Talk to us about joining a current or upcoming project.
Our collaborative process, step-by-step.
Our collaborative process, step-by-step.
Current Projects
Fertility: Oocytes
Non-invasive assessment of the developmental competence of oocytes
Currently, there are limited methods for evaluating the quality of oocytes, to determine if they have the potential to be fertilized and develop into viable embryos. Our oocyte assessment product will give more confidence to patients and clinicians about the developmental competence of oocytes obtained, enabling clinicians to make highly accurate decisions about oocyte cryopreservation or additional IVF cycles. This will also be useful for selecting batches of donor oocytes.
With 15 clinics across the US and Australia already committed, we are looking expand the collaboration, ensuring it has access to a large and globally diverse dataset to underpin development of the commercial product.
Register your interest for more information.